It is a problem but a good problem to have...I know some here think the rollout happened too slow but the fact is it's happening too quickly, putting a significant strain on cash flow...Paying for product that has a few week lead time before reimbursement occurs by distributors...having to fund inventory for reorders and market expansion and a bottle neck is created...Q1 revs are gonna be big and Q2 revs gonna be bigger..Hopefully Rich will turn over a new leaf post Q1 ER...A lot of longs are breathing down his neck to open the lines of communication...I don't mind non toxic dilution as long as it's accretive...Financing additional inventory is okay with me...The toxic debt holders are at Bay for now...They're gonna give Rich some time to see if he can make this work
Market Data 
Markets 
AI
